수술 중 영상 진단 시장 : 제품 유형별, 기동성별, 수술 접근별, 기술 통합별, 용도별 시장 예측(2026-2032년)

The Intraoperative Imaging Market is projected to grow by USD 7.28 billion at a CAGR of 7.42% by 2032.

The intraoperative imaging market sits at the center of precision surgery, combining real-time visualization, surgical navigation, robotics, and advanced image-guided intervention. Hospitals are adopting mobile C-arms, intraoperative MRI, intraoperative CT, ultrasound, endoscopy, and fluorescence imaging to improve lesion localization, implant placement, tumor margin assessment, and procedural confidence.

Demand is supported by documented growth in minimally invasive surgery, neurosurgery, orthopedic reconstruction, cardiovascular intervention, and oncology care. Verified signals from regulatory clearances, hospital capital planning, and peer-reviewed clinical literature show a clear shift toward hybrid operating rooms, AI-enabled imaging workflows, and integrated platforms that reduce avoidable repeat procedures while improving surgical decision-making.

Transformative Shifts in Surgical Imaging

The market is moving from standalone imaging equipment toward connected surgical ecosystems. Operating rooms increasingly integrate imaging devices with navigation systems, robotic platforms, electronic health records, and picture archiving and communication systems to enable data continuity before, during, and after surgery.

Key transformation drivers include rising procedure complexity, aging populations, increased trauma and orthopedic volumes, and growing clinical acceptance of image-guided surgery. Procurement decisions are also changing: hospitals now assess workflow compatibility, radiation dose management, service uptime, cybersecurity, staff training, and interoperability alongside image quality and acquisition cost.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the intraoperative imaging workflow. AI-assisted image reconstruction, automated segmentation, anatomy recognition, dose optimization, registration, and workflow orchestration are helping surgical teams improve speed and consistency while reducing manual interpretation burden.

The strongest near-term impact is in decision support rather than autonomous surgery. Regulatory-cleared AI imaging tools and peer-reviewed clinical studies support expanding use in radiology, surgical planning, and image interpretation, while intraoperative adoption depends on clinical validation, explainability, data governance, cybersecurity, and integration with hospital IT systems.

Key Regional Insights Across Global Markets

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in tertiary hospitals, robotic surgery programs, advanced operating rooms, and digital imaging infrastructure. North America remains a leading adoption region due to high surgical volumes, established reimbursement pathways, regulatory-cleared technologies, strong academic medical centers, and hospital investment in hybrid operating suites.

Europe is shaped by the European Union Medical Device Regulation, public hospital modernization, and demand for high-precision oncology, neurosurgery, cardiovascular, and orthopedic procedures. Latin America shows selective growth in private hospital networks and urban specialty centers, especially in Brazil and Mexico. The Middle East is investing in specialty hospitals, complex care, and medical tourism, while Africa is developing capacity through public-private partnerships, donor-supported infrastructure, and targeted upgrades to imaging access in referral hospitals.

Key Group Insights for Strategic Positioning

ASEAN demand is supported by hospital expansion in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with private providers and medical tourism hubs leading adoption of advanced surgical imaging. The GCC is prioritizing high-acuity care, tertiary hospitals, digital health strategies, and international-standard clinical services, making intraoperative imaging relevant for neurosurgery, orthopedics, spine surgery, trauma, and oncology centers.

The European Union is driven by regulatory harmonization, clinical quality standards, reimbursement discipline, and public procurement requirements that emphasize safety, evidence, and lifecycle value. BRICS countries combine large patient populations with uneven infrastructure and rising surgical demand, creating strong strategic relevance for scalable, cost-effective imaging platforms. G7 markets lead in installed base maturity, clinical research, digital surgery adoption, and premium technology deployment, while NATO members benefit from trauma care readiness, emergency preparedness, and defense-linked medical innovation that supports advanced imaging capabilities.

Key Country Insights for Intraoperative Imaging

The United States leads in premium intraoperative imaging adoption through large academic hospitals, ambulatory surgery centers, and integrated delivery networks focused on complex neurosurgery, spine, orthopedic, cardiovascular, and oncology procedures. Canada emphasizes evidence-based procurement and provincial health technology assessment, Mexico is advancing private hospital modernization and cross-border care capacity, and Brazil anchors Latin American demand through major urban specialty centers and tertiary hospitals.

The United Kingdom, Germany, France, Italy, and Spain prioritize quality outcomes, public hospital efficiency, surgical waiting-list management, and compliance with European device standards, while Russia faces procurement constraints, technology access challenges, and localization pressures. China is scaling domestic and imported imaging platforms through hospital expansion and surgical digitization, India is expanding high-volume surgical capacity across public and private systems, Japan and South Korea emphasize precision surgery, robotics, and advanced imaging quality, and Australia supports adoption through advanced hospital infrastructure, accreditation, and strong clinical governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperability, service reliability, and clinical workflow value over device-level differentiation alone. Vendors that integrate imaging with navigation, robotics, AI analytics, cybersecurity controls, radiation dose management, and hospital data systems will be better positioned for enterprise purchasing decisions.

Strengthen regulatory evidence, real-world performance data, cybersecurity documentation, remote service capabilities, and surgeon training programs. Hospitals should align capital planning with procedure mix, room utilization, staffing requirements, radiation safety, sterilization workflows, and total cost of ownership to ensure intraoperative imaging investments deliver measurable clinical and operational value.

Research Methodology and Evidence Base

This executive summary is built from verified secondary research, including regulatory databases, health authority publications, hospital procurement trends, peer-reviewed clinical literature, technology assessment documents, clinical guidelines, and recognized healthcare data sources such as WHO, OECD, FDA, EMA, and national health agencies.

Insights were triangulated across technology adoption, surgical demand, regional infrastructure, reimbursement patterns, regulatory pathways, hospital digital maturity, and competitive activity. The methodology emphasizes evidence-backed interpretation and avoids unsupported market-size, market-share, and forecasting claims, ensuring decision-ready analysis for stakeholders in the intraoperative imaging market.

Conclusion and Strategic Outlook

Intraoperative imaging is becoming a foundational technology for precision surgery, hybrid operating rooms, and image-guided intervention. Its value is expanding beyond visualization to include navigation, workflow intelligence, radiation dose management, surgical confidence, and clinical decision support.

The strongest opportunities are for organizations that combine proven imaging performance with AI readiness, interoperability, cybersecurity, and service excellence. As surgical complexity increases worldwide, intraoperative imaging will remain a critical enabler of safer procedures, better operative confidence, and more efficient surgical care delivery.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Intraoperative Imaging Market, by Product Type

• 7.1. Imaging Systems
• 7.2. Navigation Systems
• 7.3. Software & Visualization Tools
• 7.4. Accessories

8. Intraoperative Imaging Market, by Mobility

• 8.1. Fixed Imaging Systems
• 8.2. Mobile Imaging Systems

9. Intraoperative Imaging Market, by Surgical Approach

• 9.1. Open Surgery
• 9.2. Minimally Invasive Surgery

10. Intraoperative Imaging Market, by Technology Integration

• 10.1. Image-Guided Surgery
• 10.2. AI-Enabled Imaging
• 10.3. Robotic-Assisted Imaging
• 10.4. Augmented Reality

11. Intraoperative Imaging Market, by Application

• 11.1. Cardiovascular
• 11.2. General Surgery
• 11.3. Neurosurgery
• 11.4. Orthopedic
• 11.5. Urology

12. Intraoperative Imaging Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Intraoperative Imaging Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Intraoperative Imaging Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Allengers Medical Systems Limited
• 16.2. Analogic Corporation
• 16.3. BK Medical Holding Company, Inc.
• 16.4. Brainlab AG
• 16.5. Canon Medical Systems Corporation
• 16.6. Carestream Health, Inc.
• 16.7. FUJIFILM Holdings Corporation
• 16.8. GE HealthCare
• 16.9. Hitachi, Ltd.
• 16.10. Hologic, Inc.
• 16.11. IMRIS Imaging, Inc.
• 16.12. Koninklijke Philips N.V.
• 16.13. Medistim ASA
• 16.14. Medtronic plc
• 16.15. Mobius Imaging, LLC
• 16.16. NeuroLogica Corporation
• 16.17. Orthoscan, Inc.
• 16.18. Perlove Medical Technology Co., Ltd.
• 16.19. Planmed Oy
• 16.20. Samsung Medison Co., Ltd.
• 16.21. Shimadzu Corporation
• 16.22. Siemens Healthineers AG
• 16.23. SternMed GmbH
• 16.24. Stryker Corporation
• 16.25. Trivitron Healthcare Pvt. Ltd.
• 16.26. United Imaging Healthcare Co., Ltd.
• 16.27. Xoran Technologies LLC
• 16.28. Ziehm Imaging GmbH